Amyloid Light Chain Amylodosis
Showing 1 - 25 of 5,951
Amyloid, Amyloid Cardiomyopathy Trial in Pisa (18F-florbetaben PET/CT)
Recruiting
- Amyloid
- Amyloid Cardiomyopathy
- 18F-florbetaben PET/CT
-
Pisa, ItalyFondazione Toscana Gabriele Monasterio
Sep 16, 2023
Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)
Recruiting
- Amyloidosis, Primary
- Cardiomyopathy
- F-18 florbetapir/C-11 acetate PET
- +2 more
-
Boston, MassachusettsBrigham and Womens' Hospital
Oct 23, 2022
Relapsed/Refractory Multiple Myeloma, Amyloid Light-chain Amyloidosis Trial (SAR445514)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- Amyloid Light-chain Amyloidosis
- (no location specified)
Apr 20, 2023
Amyloid, Amyloidosis, AL Amyloidosis Trial in New York (Selinexor, Dexamethasone)
Suspended
- Amyloid
- +2 more
-
New York, New YorkWeill Cornell Medicine - Multiple Myeloma Center
May 17, 2022
Left and Right Ventricular Global Strain After Chemotherapy in
Recruiting
- Amyloid Cardiomyopathy
- +2 more
- Left and Right Ventricular Global Strain Imaging
-
Istanbul, Fatih, TurkeyIstanbul University-Cerrahpasa
Aug 11, 2022
Left Atrial Strain and Supraventricular Arrhythmia Burden in
Recruiting
- Supraventricular Arrhythmia
- +3 more
- Left Atrial Strain Imaging
- Electrocardiography
-
Istanbul, TurkeyIstanbul University-Cerrahpasa
Aug 10, 2022
Screening for Systemic Amyloidosis Via the Ligamentum Flavum
Completed
- Amyloid
- +4 more
- Biopsy
-
Cleveland, OhioCleveland Clinic
Dec 21, 2021
Hereditary Transthyretin Amyloidosis
Recruiting
- Amyloidosis
- +6 more
-
Cleveland, OhioCleveland Clinic
Mar 11, 2022
Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,
Active, not recruiting
- Light Chain Deposition Disease
- Primary Systemic Amyloidosis
- pomalidomide
- +3 more
-
Denver, Colorado
- +4 more
Jan 20, 2023
Amyloidosis Trial in Berkeley, Sacramento, San Jose (I124-AT01 only)
Active, not recruiting
- Amyloidosis
- I124-AT01 only
-
Berkeley, California
- +2 more
Sep 12, 2022
AL Amyloidosis Trial in Boston (Venetoclax, Dexamethasone)
Terminated
- AL Amyloidosis
-
Boston, MassachusettsTufts Medical Center
Aug 19, 2020
Obstructive Sleep Apnea Syndrome With Residual Excessive Daytime
Recruiting
- Sleep Apnea Syndromes
- Treatment
-
Oggebbio, ItalyIstituto Auxologico Italiano
Mar 21, 2023
Samples and Clinical Data From Patients With Amyloid Diseases
Recruiting
- Multiple Myeloma
- clonality analysis
- +6 more
-
Boston, MassachusettsBoston University Cancer Research Center
Jan 28, 2023
Cardiac Amyloidosis Trial in Seoul
Recruiting
- Cardiac Amyloidosis
-
Seoul, Korea, Republic ofSamsung Medical Center
Sep 6, 2022
AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)
Not yet recruiting
- AL Amyloidosis
- Venetoclax Oral Tablet, 200 mg
- +9 more
-
New York, New YorkNew York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022
Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)
Withdrawn
- Amyloidosis
- Light Chain (AL) Amyloidosis
- Bendamustine Hydrochloride
- Isatuximab
- (no location specified)
Dec 29, 2022
AL Amyloidosis Trial (procedure, drug, other)
Not yet recruiting
- AL Amyloidosis
- Autologous Hematopoietic Stem Cell Transplantation
- +15 more
- (no location specified)
Aug 28, 2023
NF-L Chain Measurement in Acute Ischemic Stroke
Not yet recruiting
- Acute Stroke
- Measurement of neurofilament light chain
- (no location specified)
Oct 13, 2023
Lumbar Spine Stenosis Specimens for Identification of
Not yet recruiting
- Lumbar Spinal Stenosis
- +5 more
- Tc99-PYP or Tc99-HDMP Scan
-
Beverly Hills, California
- +5 more
Sep 12, 2023
Primary Systemic Amyloidosis Trial in Milwaukee (Doxycycline)
Completed
- Primary Systemic Amyloidosis
-
Milwaukee, WisconsinFroedtert & Medical College of Wisconsin
Jun 18, 2021